| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 372 | 2015 |
| ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial Ø Torkildsen, S Wergeland, S Bakke, AG Beiske, KS Bjerve, H Hovdal, ... Archives of neurology 69 (8), 1044-1051, 2012 | 166 | 2012 |
| Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment KI Løken-Amsrud, T Holmøy, SJ Bakke, AG Beiske, KS Bjerve, ... Neurology 79 (3), 267-273, 2012 | 153 | 2012 |
| Neurofilament light chain predicts disease activity in relapsing-remitting MS KN Varhaug, C Barro, K Bjørnevik, KM Myhr, Ø Torkildsen, S Wergeland, ... Neurology: Neuroimmunology & Neuroinflammation 5 (1), e422, 2017 | 148 | 2017 |
| Dietary vitamin D3 supplements reduce demyelination in the cuprizone model S Wergeland, Ø Torkildsen, KM Myhr, L Aksnes, SJ Mørk, L Bø PloS one 6 (10), e26262, 2011 | 110 | 2011 |
| Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis S Kvistad, KM Myhr, T Holmøy, S Bakke, AG Beiske, KS Bjerve, H Hovdal, ... Multiple Sclerosis Journal 20 (14), 1833-1840, 2014 | 84 | 2014 |
| Body mass index influence interferon-beta treatment response in multiple sclerosis SS Kvistad, KM Myhr, T Holmøy, JŠ Benth, S Wergeland, AG Beiske, ... Journal of neuroimmunology 288, 92-97, 2015 | 74 | 2015 |
| Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model S Fjær, L Bø, A Lundervold, KM Myhr, T Pavlin, Ø Torkildsen, ... PLoS One 8 (12), e84162, 2013 | 66 | 2013 |
| Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis KI Løken-Amsrud, KM Myhr, SJ Bakke, AG Beiske, KS Bjerve, BT Bjørnarå, ... Multiple Sclerosis Journal 19 (4), 451-457, 2013 | 59 | 2013 |
| Effect of high‐dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model AE Nystad, S Wergeland, L Aksnes, KM Myhr, L Bø, Ø Torkildsen Apmis 122 (12), 1178-1186, 2014 | 58 | 2014 |
| IL‐10 promoter haplotype influence on interferon treatment response in multiple sclerosis S Wergeland, A Beiske, H Nyland, H Hovdal, D Jensen, JP Larsen, ... European Journal of Neurology 12 (3), 171-175, 2005 | 58 | 2005 |
| The cuprizone model: regional heterogeneity of pathology S Wergeland, Ø Torkildsen, KM Myhr, SJ Mørk, L Bø Apmis 120 (8), 648-657, 2012 | 51 | 2012 |
| Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations M König, ÅR Lorentzen, HM Torgauten, S Schikora-Rustad, EB Vaage, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 19-22, 2023 | 46 | 2023 |
| Vitamin D, HLA‐DRB 1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients S Wergeland, KM Myhr, KI Løken‐Amsrud, AG Beiske, KS Bjerve, ... European journal of neurology 23 (6), 1064-1070, 2016 | 43 | 2016 |
| Fat‐soluble vitamins as disease modulators in multiple sclerosis Ø Torkildsen, KI Løken‐Amsrud, S Wergeland, KM Myhr, T Holmøy Acta neurologica scandinavica 127, 16-23, 2013 | 43 | 2013 |
| The N orwegian M ultiple S clerosis R egistry and B iobank KM Myhr, N Grytten, Ø Torkildsen, S Wergeland, L Bø, JH Aarseth Acta Neurologica Scandinavica 132, 24-28, 2015 | 38 | 2015 |
| Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity T Holmøy, KI Løken-Amsrud, SJ Bakke, AG Beiske, KS Bjerve, H Hovdal, ... PLoS One 8 (9), e75021, 2013 | 37 | 2013 |
| Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis E Røsjø, KM Myhr, KI Løken-Amsrud, SJ Bakke, AG Beiske, KS Bjerve, ... Journal of neuroimmunology 271 (1-2), 60-65, 2014 | 36 | 2014 |
| Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model S Fjær, L Bø, KM Myhr, Ø Torkildsen, S Wergeland Neurochemistry International 83, 28-40, 2015 | 35 | 2015 |
| Alpha-tocopherol and MRI outcomes in multiple sclerosis–association and prediction KI Løken-Amsrud, KM Myhr, SJ Bakke, AG Beiske, KS Bjerve, BT Bjørnarå, ... PloS one 8 (1), e54417, 2013 | 35 | 2013 |
